GeneDx Holdings

US · WGS #2702 by market cap Listed 1970

68.53 -2.99 -4.18%

Live - 5344 symbols - heartbeat 111s ago · 2026-10-08 08:30

Pre-market 68.00 -0.77%

After-hours 68.53 0.00%

Overnight 68.50 -0.04%

Market cap: 2.04B
P/E (TTM): -18.93
P/B: 8.37
EPS: -0.73
Div yield: 0.00%
52W pos: 26%

Reader sentiment Are you bullish or bearish on WGS?

Anonymous reader poll. Unscientific, not investment advice.

About GeneDx Holdings

GeneDx Holdings Corp. is a rare disease diagnosis company, with a mission to empower everyone to live their healthiest life through genomics. The firm combines clinical expertise, advanced technology, and the power of GeneDx Infinity. This foundation powers GeneDx's ExomeDx and GenomeDx tests, enabling clinicians to deliver precise, fast, and actionable diagnoses. The Infinity also fuels discovery for biopharma with AI-driven genomic intelligence. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Founded: 2020
CEO: Ms. Katherine A. Stueland
Employees: 1,300
Headquarters: Stamford, Connecticut, United States of America
Fiscal year end: 12-31
Website: genedx.com

Company profile

Exchange: US
Symbol: WGS
Market-cap rank: #2702
Listing date: 1970-01-01
Market cap: 2.04B
Float cap: 1.40B
Shares out: 29.82M
Float shares: 20.44M

Sectors & themes

Diagnostics & Research Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 08:30:23 · For reference only, not investment advice and not tailored to your situation.